Kynam Capital Management, LP Tyra Biosciences, Inc. Transaction History
Kynam Capital Management, LP
- $1.19 Billion
- Q1 2025
A detailed history of Kynam Capital Management, LP transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Kynam Capital Management, LP holds 2,406,067 shares of TYRA stock, worth $23.4 Million. This represents 1.89% of its overall portfolio holdings.
Number of Shares
2,406,067
Previous 530,478
353.57%
Holding current value
$23.4 Million
Previous $7.37 Million
203.49%
% of portfolio
1.89%
Previous 0.47%
Shares
6 transactions
Others Institutions Holding TYRA
# of Institutions
119Shares Held
55.6MCall Options Held
25KPut Options Held
5.4K-
Ra Capital Management, L.P. Boston, MA10.6MShares$103 Million2.05% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA4.14MShares$40.3 Million95.26% of portfolio
-
Alta Partners Management Company, L.P. Jackson, WY4.08MShares$39.7 Million90.83% of portfolio
-
Nextech Invest Ag4.06MShares$39.4 Million10.51% of portfolio
-
Nextech Invest, Ltd. Zurich, V84.06MShares$39.4 Million8.77% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $408M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...